Healthcare Innovation July 23, 2024
David Raths

Ohio State Genomic Health plans to enroll 100,000 participants over four years and will screen for variants in genes associated with breast and ovarian cancer, colorectal cancer and high cholesterol

The Ohio State University Wexner Medical School and genomics company Helix are launching the largest precision health initiative in Ohio.

The program, named Ohio State Genomic Health, plans to enroll 100,000 participants over four years and will provide information about potential risks for health conditions by screening for variants in genes associated with breast and ovarian cancer, colorectal cancer and high cholesterol. Nationwide, nearly five million people are at an increased risk for one of these conditions.

Population genomics efforts are becoming more common. Besides the national NIH-sponsored All...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Pharma / Biotech, Precision Medicine, States
How State Policy Makers Can Tackle Medical Debt: Lessons From North Carolina
State-Level Initiatives in Drug Pricing, PBM Reform, and Utilization Management
Best Medicare Advantage plan companies in each state: US News
Lawsuit Challenging Nevada’s Public Option Dismissed
Pennsylvania lawmakers take aim at hospital M&A: 4 things to know

Share This Article